Introduction

Mitochondrial-derived peptides (MDPs) represent a paradigm shift in our understanding of mitochondrial biology. Long regarded primarily as cellular powerhouses, mitochondria are now recognized as active signaling organelles that encode and release bioactive peptides with systemic metabolic and cytoprotective effects. MOTS-c, Humanin, and SHLP2-6 are encoded within the mitochondrial 16S rRNA and 12S rRNA genes, representing a previously unrecognized layer of inter-organellar and inter-tissue communication.

The discovery of MDPs by Dr. Pinchas Cohen and colleagues at USC has opened new avenues in mitochondrial signaling research, suggesting that the mitochondrial genome functions as more than a respiratory chain blueprint—it actively participates in the regulation of metabolism, stress resistance, and longevity.

Humanin: The Prototype MDP

Humanin is a 24-amino-acid peptide (originally 21 amino acids, extended by three N-terminal residues in its most potent form) encoded within the mitochondrial 16S rRNA gene. Its discovery in 2001 emerged from a functional screening for neuroprotective factors against Alzheimer's disease-related insults. Humanin binds to a trimeric receptor complex consisting of CNTFR, WSX-1, and gp130, activating JAK/STAT and ERK signaling cascades that promote cell survival under conditions of oxidative stress, Aβ toxicity, and serum deprivation.

Beyond neuroprotection, humanin has demonstrated cardioprotective, renoprotective, and metabolic regulatory effects. Circulating humanin levels decline with age and are inversely correlated with insulin resistance, suggesting a role as a biomarker and potential therapeutic target for age-related metabolic decline.

MOTS-c: A Mitochondrially Encoded Exercise Mimetic

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino-acid peptide that translocates to the nucleus under metabolic stress, regulating adaptive nuclear gene expression. MOTS-c administration in mice prevented high-fat-diet-induced obesity and insulin resistance by increasing skeletal muscle glucose uptake through AMPK activation independent of insulin signaling. Notably, MOTS-c levels increase acutely following exercise, positioning this peptide as an "exercise mimetic" with potential therapeutic applications for metabolic syndrome.

The nuclear translocation of MOTS-c represents a novel example of retrograde signaling from mitochondria to the nucleus, with MOTS-c directly binding to nuclear factor erythroid 2-related factor 2 (NRF2) response elements to modulate antioxidant gene expression. This mitochondria-to-nucleus signaling axis adds a dimension to cellular stress responses beyond traditional ROS-mediated pathways.

SHLP Peptides: The Expanding MDP Family

Small Humanin-Like Peptides (SHLPs) 1-6, ranging from 20 to 38 amino acids, were identified through bioinformatic screening of the mitochondrial 16S rRNA open reading frames. SHLP2 and SHLP3 demonstrate potent anti-apoptotic activity in neuronal cell lines, while SHLP6 increases mitochondrial oxygen consumption rate and fatty acid oxidation in myotubes. The functional diversity within the SHLP family suggests that mitochondrial rRNA genes function as polycistronic peptide-coding sequences with distinct biological activities encoded by adjacent open reading frames.

Conclusion

Mitochondrial-derived peptides represent an exciting frontier at the intersection of mitochondrial biology, metabolism, and aging research. The recognition that mitochondrial genomes encode bioactive signaling peptides fundamentally reframes our understanding of organellar evolution and inter-tissue communication, opening novel therapeutic strategies for metabolic disorders, neurodegenerative diseases, and age-related functional decline.